Work Song Lyrics, Bart Becht Coty, Criehaven Island, Maine, Cinelab 8mm Order Form, Ilya Kovalchuk Hockeydb, Chanel Sneakers Men's, Kam Chancellor Retired, Gmail Com Ssl, Insecure Season 4 Episode 10 Full Episode, 2007 Milwaukee Brewers Roster, Nestle Controversy 2019, Double Room Description, Tweed Daily News, Trimetals Bike Storage, Mitch Marner Tumblr, Best Catholic Universities In Europe, Sam Lafferty Hollidaysburg, Vision Of Starbucks, Warning Example Sentence, Mac Cremesheen Lipstick Swatches, Helmerich And Payne Dividend Cut, Tucker Carlson Youtube Today, Rhode Island Soccer Tournament, Sephora Matte Liquid Lipstick, Why Is It Hard To Find Someone To Connect With, Anthrax Outbreak Uk, Bombing Of Hiroshima And Nagasaki Research Paper, Crystal Swan Movie Stream, City Of San Diego 401k Plan, Piercing Light Lucian, Walmart Logo Svg, Budweiser Stage Covid, Collingwood Football Club Membership, Accurate Bmi Visualizer, Ty Domi Son, Nars Cosmetics Revenue 2018, Red Spinel Price, Northside Chronicle Editor, Concerts In Tokyo September 2019, Shimano Chronarch 50e, New Russian Destroyers, Seline Hizli Deadwater Fell, Was Germany Occupied By Germany In Ww2, St Clare Commons Jobs, Vintage Fendi Baguette, Gucci Shirt Price In Dubai, Amazon Fire 10, Lovable Dork Meaning, Trieste Airport Destinations, Boo Ghost Game, Belfour Whiskey Review, Dodger Minor League Players 2020, John Hightower Comparison, Youtube Manchester United Foundation, Clelin Ferrell Madden, Wilco - Love Is Everywhere,

Trillium Therapeutics Inc. is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. Trillium is an immuno-oncology company developing innovative therapies for the treatment of cancer. Infinite Hope. All rights reserved. CAMBRIDGE, Mass., May 15, 2020 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today reported financial and operating results for the three months ended March 31, 2020. Trillium Therapeutics Inc. (NASDAQ/TSX:TRIL) is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. TSX: MDNA | OTCQB: MDNAF | Medicenna is a clinical stage immunotherapy company developing novel highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Cytokines (ECs). The company’s two clinical programs, TTI-621 and TTI-622, target CD47, a “do not eat” signal that cancer cells frequently use to evade the immune system.Net loss for the three months ended March 31, 2020 of $70.1 million was higher than the loss of $8.0 million for the three months ended March 31, 2019, due mainly to revaluation losses recorded on the warrant liability and deferred share unit (“DSU”) liability of $55.2 million and $9.3 million respectively, as a result of a higher common share price at March 31, 2020 than at December 31, 2019.  In the prior year period, recoveries of $0.5 million and $0.4 million were recorded relating to the fair valuation of the warrant liability and DSU liability, respectively. Accordingly, all outstanding DSUs issued for director compensation will become equity-settled and classified as equity instead of as a liability, subject to shareholder approval of the 2020 Omnibus Incentive Plan at the Annual General and Special Meeting to be held on June 30, 2020. The current DSU plan allows for only cash-settlement of DSUs that are redeemed by directors when their service ends with the Company. To conserve the use of cash for operations, the board of directors has approved the 2020 Omnibus Incentive Plan that provides for equity settlement of DSUs and all directors have agreed to have their existing DSUs administered under the terms of the new plan. Trillium Therapeutics Inc. is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. Joyce has 3 jobs listed on their profile. Trillium is an immuno-oncology company developing innovative therapies for the treatment of cancer. Find the latest Trillium Therapeutics Inc. (TRIL) stock quote, history, news and other vital information to help you with your stock trading and investing. Se Bolette Bossens profil på LinkedIn, världens största yrkesnätverk. We continue to benefit from the restructuring of the Company’s footprint and resetting of our strategy in 2019.”© 1985 - 2020 BioSpace.com. Trillium Therapeutics Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. View Joyce Lin’s profile on LinkedIn, the world's largest professional community. Powered by Madgex Job Board SoftwareCOVID-19 Pandemic and Business ContinuityTrillium’s outstanding warrants are a non-cash liability, and revaluation losses on the Company’s warrant liability balance are of a non-cash nature. Trillium Therapeutics to Present Data on CD47 Blocker TTI-622 in Advanced Relapsed or Refractory Lymphoma at the ASCO20 Virtual Scientific Program Published: May 13, … See the complete profile on LinkedIn and discover Joyce’s connections and jobs at similar companies. Appili Therapeutics is building a team of drug development professionals dedicated to advancing novel therapeutics in the area of infectious disease. “We reported encouraging data for our novel CD47 checkpoint inhibitors TTI-621 and TTI-622, raised $117 million in funding from leading healthcare investors, and made substantial progress by advancing our ongoing TTI-621 and TTI-622 dose escalation studies.